In This Section      
 

The Atlantic Cardiovascular Patient Outcomes Research Team - Atlantic C-PORT

 Principal Investigator: Thomas Aversano, MD

Research Focus

  • Our research is centered on the safety, efficacy and outcomes of PCI performed at hospitals without on-site cardiac surgery.

Active Projects

C-PORT Randomized Studies and Registries; New Jersey Angioplasty Demonstration Project; InCar-decision support tools for performance of PCI at hospitals without on-site cardiac surgery.

For more information please visit Cport.org.

Collaborators

Selected Bibliography

  • Heparin versus bivalirudin for non-primary percutaneous coronary intervention: A post-Hoc analysis of the CPORT-E trial. Czarny MJ, Hwang CW, Naiman DQ, Lemmon CC, Hasan RK, Wang T, Aversano T. Catheter Cardiovasc Interv. 2017 Feb 4. doi: 10.1002/ccd.26953. [Epub ahead of print]
  • Outcomes of PCI at hospitals with or without on-site cardiac surgery. Aversano T, Lemmon CC, Liu L; Atlantic CPORT Investigators. N Engl J Med. 2012 May 10;366(19):1792-802.  Erratum in: N Engl J Med. 2012 Apr 26;366(17):1650. 
  • Percutaneous coronary intervention at centers with and without on-site surgery: a meta-analysis. Singh M, Holmes DR Jr, Dehmer GJ, Lennon RJ, Wharton TP, Kutcher MA, Aversano T, Rihal CS. JAMA. 2011 Dec 14;306(22):2487-94. 
  • Comparative effectiveness of ST-segment-elevation myocardial infarction regionalization strategies. Concannon TW, Kent DM, Normand SL, Newhouse JP, Griffith JL, Cohen J, Beshansky JR, Wong JB, Aversano T, Selker HP. Circ Cardiovasc Qual Outcomes. 2010 Sep;3(5):506-13.
  • A percutaneous coronary intervention-thrombolytic predictive instrument to assist choosing between immediate thrombolytic therapy versus delayed primary percutaneous coronary intervention for acute myocardial infarction. Kent DM, Ruthazer R, Griffith JL, Beshansky JR, Concannon TW, Aversano T, Grines CL, Zalenski RJ, Selker HP. Am J Cardiol. 2008 Mar 15;101(6):790-5. 
  • A geospatial analysis of emergency transport and inter-hospital transfer in ST-segment elevation myocardial infarction. Concannon TW, Kent DM, Normand SL, Newhouse JP, Griffith JL, Ruthazer R, Beshansky JR, Wong JB, Aversano T, Selker HP. Am J Cardiol. 2008 Jan 1;101(1):69-74. 
  • Development of systems of care for ST-elevation myocardial infarction patients: the non-percutaneous coronary intervention-capable (ST-elevation myocardial infarction referral) hospital perspective. Ellrodt G, Sadwin LB, Aversano T, Brodie B, O'Brien PK, Gray R, Hiratzka LF, Larson D. Circulation. 2007 Jul 10;116(2):e49-54
  • Comparison of mortality benefit of immediate thrombolytic therapy versus delayed primary angioplasty for acute myocardial infarction. Kent DM, Ruthazer R, Griffith JL, Beshansky JR, Grines CL, Aversano T, Concannon TW, Zalenski RJ, Selker HP. Am J Cardiol. 2007 May 15;99(10):1384-8. 
  • Improving systems of care in primary angioplasty. Watkins S, Tirabassi L, Aversano T.Cardiol Clin. 2006 Feb;24(1):79-85. Review.
  • Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. Aversano T, Aversano LT, Passamani E, Knatterud GL, Terrin ML, Williams DO, Forman SA; Atlantic Cardiovascular Patient Outcomes Research Team (C-PORT). JAMA. 2002 Apr 17;287(15):1943-51. Erratum in: JAMA 2002 Jun 26;287(24):3212.